期刊文献+

帕金森病患者儿茶酚氧位甲基转移酶基因多态性与左旋多巴诱导的运动障碍的关系 被引量:3

Association between polymorphism of COMT gene and motor fluctuation induced by levodopa in Pakinson’s disease
下载PDF
导出
摘要 目的探讨儿茶酚氧位甲基转移酶(COMT)基因第4号外显子G→A的点突变所致的基因多态性是否与帕金森病患者中左旋多巴诱导的运动障碍有关。方法采用聚合酶链反应限制性片段长度多态性的方法分析了100例帕金森病患者(分为有运动波动组和无运动波动组)与100例健康成人(对照组)COMT基因多态性。结果对照组基因型分布野生型(GG)为51%,杂合型(GA)为45%,突变纯合子型(AA)为4%。有运动波动组基因型分布分别为76%、20%、4%,无运动波动组基因型分布分别为52%、34%、14%。3组COMT的基因型分布频率有显著差异(P=0.003)。有运动波动组与无运动波动组比较,有运动波动组GG的基因型较无运动波动组显著增高;AA基因型有运动波动组较无运动波动组明显降低(P=0.033)。结论COMT基因第4号外显子G→A的点突变所致的基因多态性与左旋多巴诱导的运动障碍有关。 Objectives To investigate whether the motor fluctuation induced by levodopa in Pakinson's disease patients is associated with polymorphism of catechol -O- methyltransferase (COMT) gene caused by the point mutation of G1947→A in exon 4. Methods The polymorphism of COMT gene was analyzed in 100 healthy adult individuals and 100 PD patients by polymerase chain reaction-restriction fragment length polymorphism.The group of PD patient was divided into two subgroups in which 50 had motor fluctuation and 50 had no motor fluctuation. Results There was significant difference in the overall genotypical distribution between the patients and the controls ( P = 0.003). Compared with the patients who had no motor fluctuation , there was a trend toward increased frequency of the G/G homozygote and a trend toward decreased frequency of the A/A heterozygote in patients who had motor fluctuation. Conclusion The results suggest that the motor fluctuation induced by levodopa in Parkinson' s disease patients is associated with polymorphism of COMT gene.
出处 《中华老年心脑血管病杂志》 CAS 北大核心 2005年第3期178-180,共3页 Chinese Journal of Geriatric Heart,Brain and Vessel Diseases
关键词 帕金森病 儿茶酚O-甲基转移酶 左旋多巴 运动障碍 parkinson disease catechol O-methyltransferase levodopa movement disorders
  • 相关文献

参考文献3

二级参考文献25

  • 1Larsen JP. Sleep disorders in Paddnson's disease[J]. Adv Neurol,2003,91 : 329-334.
  • 2Comella CL. Sleep distuigances in Parkinson' s disease [ J ]. Curr Neurol Neurosci Rep, 2003,3:173-180.
  • 3Askenasy JJM. Sleep disturbanoes in parkinsonism [ J ]. J Neural Transm, 2003,110:125-150.
  • 4Tandberg E, Larsen JP, Karlsen K. A commumity-based study of sleep disorders in patients with Parkinson' s disease [ J ]. Mov Disord, 1998,13:895-899.
  • 5Factor SA, McAlarney T, Sanchez Ramos JR, et ol. Sleep disorders and sleep effect in Parkinson's disease[J]. Mov Disord, 1990,4:280-285.
  • 6Diego GB, Oscar L, Mauricio B. Patkinson's disease and sleep[J].Sleep Med Rev, 2003, 7:115-129.
  • 7Wetter TC, Stiansky K, Winkelmann J, et al. A randomized, controlled study of pergolide in patients with restless legs syndrome[J].Neurology, 1999,52: 944-950.
  • 8Olsen EJ, Boeve BF, Silber MH. Rapid eye movements sleep behavior disorder:demographic, clinical and laboratory findings in 93 cases[J], Brain, 2000,123:331-339.
  • 9comella CL, Nardine TM, Diederich NJ, et al. Sleep related violegate, injury, and REM sleep behavior disorders in multiple system atrophy[J]. Nearology, 1998,51:526-529.
  • 10Boeve BF, Silber MH, Ferman TJ, et al. REM sleep behavior disorder and degenerative dementia: an association likely reflecting Lewy body disesse[J]. Neurology, 1998,51:363-370.

共引文献13

同被引文献54

  • 1胡琦,朱遂强.帕金森病的细胞移植治疗研究[J].卒中与神经疾病,2006,13(2):125-126. 被引量:1
  • 2张丹,张建军,刘耕陶.治疗帕金森病新药:腺苷A_(2A)受体拮抗剂[J].中国药理学通报,2006,22(8):897-900. 被引量:6
  • 3褚玉霞,汪静.帕金森病研究进展分析[J].医学综述,2006,12(18):1112-1113. 被引量:24
  • 4王恒会,罗蔚锋.腺苷A_(2A)受体拮抗剂治疗帕金森病的研究进展[J].国外医学(老年医学分册),2006,27(6):244-247. 被引量:3
  • 5谢海芳,俞雯雯.细胞移植治疗帕金森病的研究及进展[J].实用中西医结合临床,2007,7(2):91-93. 被引量:1
  • 6Ahlskog JE,Muenter MD. Frequency of levodopa-related dyskinesias and motor fluctuations as esti-mated from the cumulative literature [J],Mov Dis-ord,2001,16(3); 448-458.
  • 7LottaT,Vidgren J,Tilgmann C.et al. Kinetics ofhuman soluble and membrane-bound catechol O-methyltransferase ; a revised mechanism and de-scription of the thermolabile variant of the enzyme[J].Biochemistry,1995,34(13):4202-4210.
  • 8de Lau LM,Verbaan D,Marinus J et al. Catechol-O-methyltransferase Vail 58Met and the risk of dys-kinesias in Parkinson's disease [J].Mov Disord,2012,27(1):132-135.
  • 9Lee MS,Lyoo CH,Ulmanen I,et al. Genotypes ofcatechol-O-methyltransferase and response to levo-dopa treatment in patients with Parkinson's disease[J].Neurosci Lett,2001,298(2) :131-134.
  • 10Watanabe M,Harada S,Nakamura T,et al. As-sociation between catechol-O-methyltransferase genepolymorphisms and wearing-off and dyskinesia inParkinson's disease [J].Neuropsychobiology,2003,48(4) :190-193.

引证文献3

二级引证文献23

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部